Structure Therapeutics Inc. GPCR
19.08 USD -1.28 (-6.29%)
At closeNov 6, 2026, 7:02 AM EST
19.05 -0.03 -0.16%
Pre-market · Nov 6, 7:02 AM ET
18.76 Day range 20.56
18.76 52-week range 94.90
- YTD
- -72.57%
- 1 year
- -40.76%
Financial health
Altman Z-Score
9.24 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
B-2 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 5
- P/E 1
- P/B 3
Valuation
P/E -29.0×
FY 2020 5y median -18.1× FY 2025
P/S 0.0×
FY 2020 5y median 0.0× FY 2025
P/B 2.7×
FY 2020 5y median 1.7× FY 2025
P/FCF -18.2×
FY 2020 5y median -18.3× FY 2025
EV/EBITDA -23.9×
FY 2020 5y median -18.1× FY 2025
EV/Sales 0.0×
FY 2020 5y median 0.0× FY 2025
FCF Yield -5.5%
FY 2020 5y median -5.5% FY 2025
Profitability
Gross Margin 0.0%
FY 2020 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2020 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2020 5y median 0.0% FY 2025
ROE -9.3%
FY 2020 5y median -9.3% FY 2025
ROIC -18.9%
FY 2020 5y median -22.4% FY 2025
ROA -8.9%
FY 2020 5y median -18.6% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2020 FY 2025
Operating Income -81.7%
FY 2020 FY 2025
EPS (diluted) -2.6%
FY 2020 FY 2025
Free Cash Flow -91.5%
FY 2020 FY 2025
Financial Health
Current Ratio 24.8×
FY 2020 5y median 19.1× FY 2025
Quick Ratio 24.8×
FY 2020 5y median 19.1× FY 2025
Debt / Equity 0.0×
FY 2020 5y median 0.0× FY 2025
Net Debt / EBITDA 5.7×
FY 2020 5y median 1.6× FY 2025
Interest Coverage 0.0×
FY 2020 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2020 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2020 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31